Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease

被引:0
|
作者
Papamichael, K. [1 ]
Cheifetz, A. S. [1 ]
机构
[1] Harvard Med Sch, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA 02115 USA
关键词
ULCERATIVE-COLITIS; CROHNS-DISEASE; INFLIXIMAB;
D O I
10.1111/apt.14461
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:436 / 437
页数:2
相关论文
共 50 条
  • [31] UK National Survey of Gastroenterologists' attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease
    Nigam, Gaurav B.
    Nayeemuddin, Shadab
    Kontopantelis, Evangelos
    Hayee, Bu'Hussain
    Limdi, Jimmy K.
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (01) : 22 - 29
  • [32] Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal
    Ben-Horin, S.
    Chowers, Y.
    Ungar, B.
    Kopylov, U.
    Loebstein, R.
    Weiss, B.
    Eliakim, R.
    Del Tedesco, E.
    Paul, S.
    Roblin, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 356 - 364
  • [33] Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study
    Jose Casanova, Maria
    Chaparro, Maria
    Garcia-Sanchez, Valle
    Nantes, Oscar
    Jauregui-Amezaga, Aranzazu
    Rojas-Feria, Maria
    Ramon Pineda, Juan
    Tosca, Joan
    Martinez-Montiel, Pilar
    Garcia-Lopez, S.
    Pajares, R.
    Beltran, Belen
    Barreiro-de Acosta, Manuel
    Ramos, Laura
    Perez-Martinez, Isabel
    Bermejo, Fernando
    Gonzalez-Lama, Yago
    Cajal, Manuel Domnguez
    Maria Huguet, Jose
    Sicilia, Beatriz
    Duenas-Sadornil, Carmen
    Ponferrada Diaz, Angel
    Merino, Olga
    Calvet, Xavier
    Menacho, Margarita
    Guardiola, Jordi
    Ramirez de la Piscina, Patricia
    Perez-Calle, Jose L.
    Dominguez-Antonaya, Mercedes
    Piqueras, Marta
    Fernandez Salazar, Luis
    Busquets, David
    Benitez Cantero, Jose Manuel
    Rodriguez, Cristina
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2015, 148 (04) : S476 - S476
  • [34] Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study
    Casanova, Maria Jose
    Chaparro, Maria
    Garcia-Sanchez, Valle
    Nantes, Oscar
    Leo, Eduardo
    Rojas-Feria, Maria
    Jauregui-Amezaga, Aranzazu
    Garcia-Lopez, Santiago
    Huguet, Jose Maria
    Arguelles-Arias, Federico
    Aicart, Marta
    Marin-Jimenez, Ignacio
    Gomez-Garcia, M.
    Munoz, Fernando
    Esteve, Maria
    Bujanda, Luis
    Cortes, Xavier
    Tosca, Joan
    Pineda, Juan Ramon
    Manosa, Miriam
    Llao, Jordina
    Guardiola, Jordi
    Perez-Martinez, Isabel
    Munoz, Carmen
    Gonzalez-Lama, Yago
    Hinojosa, J.
    Moron, Juan Maria Vazquez
    Martinez-Montiel, Pilar
    Rodriguez, G. E.
    Pajares, R.
    Garcia-Sepulcre, M. F.
    Hernandez-Martinez, A.
    Perez-Calle, J. L.
    Beltran, Belen
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2016, 150 (04) : S979 - S979
  • [35] Outcomes post methotrexate salvage therapy after anti-TNF loss of response in inflammatory bowel disease
    Cunningham, G.
    Kodikara, C.
    Varma, P.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 131 - 131
  • [36] Long-term probability of retreatment with anti-TNF therapy after discontinuation based on mucosal healing in inflammatory bowel disease
    Luque Carmona, A. M.
    Garcia Ortiz, J. M.
    Nunez Ortiz, A.
    De la Cruz Ramirez, M. D.
    Herrera Justiniano, J. M.
    Leo Carnerero, E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S471 - S472
  • [37] Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease
    Wang, Ming-Hsi
    Friton, Jessica J.
    Raffals, Laura E.
    Leighton, Jonathan A.
    Pasha, Shabana F.
    Picco, Michael F.
    Cushing, Kelly C.
    Monroe, Kelly
    Nix, Billy D.
    Newberry, Rodney D.
    Faubion, William A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 1036 - 1043
  • [38] Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes
    Julsgaard, Mette
    Hvas, Christian L.
    Gearry, Richard B.
    Gibson, Peter R.
    Fallingborg, Jan
    Sparrow, Miles P.
    Bibby, Bo M.
    Connell, William R.
    Brown, Steven J.
    Kamm, Michael A.
    Lawrance, Ian C.
    Vestergaard, Thea
    Svenningsen, Lise
    Baekdal, Mille
    Kammerlander, Heidi
    Walsh, Alissa
    Boysen, Trine
    Bampton, Peter
    Radford-Smith, Graham
    Kjeldsen, Jens
    Andrews, Jane M.
    Subramaniam, Kavitha
    Moore, Gregory T.
    Jensen, Nanna M.
    Connor, Susan J.
    Wildt, Signe
    Wilson, Benedicte
    Ellard, Kathrine
    Christensen, Lisbet A.
    Bell, Sally J.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 93 - 102
  • [39] Evolution after anti-TNF drug discontinuation in patients with inflammatory bowel disease (IBD): a multicenter long-term follow-up study.
    Casanova, M. J.
    Chaparro, M.
    Garcia-Sanchez, V.
    Nantes, O.
    Jauregui-Amezaga, A.
    Rojas-Feria, M.
    Pineda, J. R.
    Tosca, J.
    Martinez-Montiel, M. P.
    Luzon, L.
    Pajares, R.
    Beltran, B.
    Barreiro de-Acosta, M.
    Ramos, L.
    Perez-Martinez, I.
    Bermejo, F.
    Gonzalez-Lama, Y.
    Dominguez-Cajal, M.
    Huguet, J. M.
    Sicilia, B.
    Duenas-Sadornil, C.
    Ponferrada-Diaz, A.
    Merino, O.
    Calvet, X.
    Menacho, M.
    Guardiola, J.
    Ramirez de la Piscina, P.
    Perez-Calle, J. L.
    Dominguez-Antonaya, M.
    Piqueras, M.
    Fernandez-Salazar, L.
    Busquets, D.
    Benitez-Cantero, J. M.
    Rodriguez, C.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S329 - S329
  • [40] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
    Chanchlani, Neil
    Lin, Simeng
    Auth, Marcus K.
    Lee, Chai Leng
    Robbins, Helena
    Looi, Shi
    Murugesan, Senthil, V
    Riley, Tom
    Preston, Cathryn
    Stephenson, Sophie
    Cardozo, Wendy
    Sonwalkar, Sunil A.
    Allah-Ditta, Mohammed
    Mansfield, Lynne
    Durai, Dharmaraj
    Baker, Mark
    London, Ian
    London, Emily
    Gupta, Sanjay
    Di Mambro, Alex
    Murphy, Aisling
    Gaynor, Edward
    Jones, Kelsey D. J.
    Claridge, Andrew
    Sebastian, Shaji
    Ramachandran, Sankaranarayanan
    Selinger, Christian P.
    Borg-Bartolo, Simon P.
    Knight, Paul
    Sprakes, Michael B.
    Burton, Julie
    Kane, Patricia
    Lupton, Stephanie
    Fletcher, Aimee
    Gaya, Daniel R.
    Colbert, Roghan
    Seenan, John Paul
    MacDonald, Jonathan
    Lynch, Lucy
    McLachlan, Iain
    Shields, Stephanie
    Hansen, Richard
    Gervais, Lisa
    Jere, Mwansa
    Akhtar, Muhammad
    Black, Karen
    Henderson, Paul
    Russell, Richard K.
    Lees, Charlie W.
    Derikx, Lauranne A. A. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263